JPMorgan Chase & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07B | Sell |
|
|||||
|
2025
Q1 | $3.59B | Sell |
|
|||||
|
2024
Q4 | $5.03B | Sell |
|
|||||
|
2024
Q3 | $7.87B | Sell |
|
|||||
|
2024
Q2 | $8.7B | Buy |
|
|||||
|
2024
Q1 | $7.44B | Buy |
|
|||||
|
2023
Q4 | $6.35B | Sell |
|
|||||
|
2023
Q3 | $6.08B | Buy |
|
|||||
|
2023
Q2 | $4.7B | Buy |
|
|||||
|
2023
Q1 | $5.21B | Buy |
|
|||||
|
2022
Q4 | $4.41B | Buy |
|
|||||
|
2022
Q3 | $3.93B | Buy |
|
|||||
|
2022
Q2 | $3.36B | Buy |
|
|||||
|
2022
Q1 | $3.47B | Buy |
|
|||||
|
2021
Q4 | $2.9B | Buy |
|
|||||
|
2021
Q3 | $2.48B | Buy |
|
|||||
|
2021
Q2 | $2.12B | Buy |
|
|||||
|
2021
Q1 | $1.44B | Buy |
|
|||||
|
2020
Q4 | $1.12B | Buy |
|
|||||
|
2020
Q3 | $1.1B | Buy |
|
|||||
|
2020
Q2 | $1.12B | Buy |
|
|||||
|
2020
Q1 | $600M | Buy |
|
|||||
|
2019
Q4 | $458M | Buy |
|
|||||
|
2019
Q3 | $126M | Sell |
|
|||||
|
2019
Q2 | $171M | Sell |
|
|||||
|
2019
Q1 | $532M | Buy |
|
|||||
|
2018
Q4 | $96.5M | Buy |
|
|||||
|
2018
Q3 | $92.8M | Buy |
|
|||||
|
2018
Q2 | $52.3M | Sell |
|
|||||
|
2018
Q1 | $56.2M | Sell |
|
|||||
|
2017
Q4 | $81M | Sell |
|
|||||
|
2017
Q3 | $150M | Buy |
|
|||||
|
2017
Q2 | $110M | Sell |
|
|||||
|
2017
Q1 | $108M | Sell |
|
|||||
|
2016
Q4 | $124M | Sell |
|
|||||
|
2016
Q3 | $417M | Sell |
|
|||||
|
2016
Q2 | $502M | Sell |
|
|||||
|
2016
Q1 | $528M | Sell |
|
|||||
|
2015
Q4 | $1.44B | Buy |
|
|||||
|
2015
Q3 | $1.18B | Buy |
|
|||||
|
2015
Q2 | $1.24B | Buy |
|
|||||
|
2015
Q1 | $1.03B | Buy |
|
|||||
|
2014
Q4 | $723M | Buy |
|
|||||
|
2014
Q3 | $557M | Sell |
|
|||||
|
2014
Q2 | $475M | Buy |
|
|||||
|
2014
Q1 | $473M | Sell |
|
|||||
|
2013
Q4 | $509M | Sell |
|
|||||
|
2013
Q3 | $800M | Sell |
|
|||||
|
2013
Q2 | $650M | Buy |
|